• Return to Headlines

Shares of EXEL Down 24.2% Since Downtrend Call on Shares

By James Quinn

SmarTrend identified a Downtrend for Exelixis Inc (NASDAQ:EXEL) on February 28th, 2018 at $26.69. In approximately 2 months, Exelixis Inc has returned 24.23% as of today's recent price of $20.22.

Over the past year, Exelixis Inc has traded in a range of $7.20 to $32.50 and is now at $20.22, 181% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.3%.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Exelixis Inc.

Log in and add Exelixis Inc (EXEL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exelixis inc

Ticker(s): EXEL